12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga · 2d ago
Gainers
- Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 35.9% to $7.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.2 million.
- Biodexa Pharmaceuticals (NASDAQ:BDRX) stock moved upwards by 17.49% to $1.41. The company's market cap stands at $1.2 million.
- Picard Medical (AMEX:PMI) shares rose 12.81% to $5.79. The company's market cap stands at $10.5 million. As per the press release, Q2 earnings came out 4 days ago.
- Kura Oncology (NASDAQ:KURA) stock increased by 10.48% to $13.7. The company's market cap stands at $1.1 billion.
- Precision BioSciences (NASDAQ:DTIL) shares moved upwards by 9.58% to $9.26. The market value of their outstanding shares is at $233.2 million.
- Tenax Therapeutics (NASDAQ:TENX) stock rose 9.18% to $2.02. The market value of their outstanding shares is at $49.0 million.
Losers
- OSR Health (NASDAQ:OSRH) shares declined by 16.0% to $0.21 during Tuesday's pre-market session. The market value of their outstanding shares is at $8.7 million.
- Valion Bio (NASDAQ:VBIO) shares declined by 14.76% to $0.14.
- ZeroStack (NASDAQ:ZSTK) stock decreased by 9.1% to $4.6. The company's market cap stands at $12.2 million.
- NexGel (NASDAQ:NXGL) stock declined by 8.56% to $0.35. The company's market cap stands at $3.7 million.
- Innovative Eyewear (NASDAQ:LUCY) shares fell 8.04% to $1.03. The company's market cap stands at $9.6 million.
- Beyond Air (NASDAQ:XAIR) shares declined by 7.34% to $4.55. The company's market cap stands at $4.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.